ARMATA PHARMACEUTICALS, INC. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
ARMATA PHARMACEUTICALS, INC. (ARMP) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $2.40 million as of 2021-12-31, per its 10-K filed 2022-03-17.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2022-03-17
- 2021-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $2.40M.
- 2018-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $630.00K.
- 2017-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $1.10M.
- 2016-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $1.40M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2021-12-31 | $2.40M 10-K · filed 2022-03-17 |
| 2018-12-31 | $630.00K 10-K · filed 2019-03-25 |
| 2017-12-31 | $1.10M 10-K · filed 2018-03-14 |
| 2016-12-31 | $1.40M 10-K · filed 2017-03-27 |
| 2016-09-30 | $1.90M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $2.20M 10-Q · filed 2016-08-15 |
| 2015-12-31 | $3.60M 10-K · filed 2016-03-30 |
| 2015-09-30 | $4.40M 10-Q · filed 2015-11-16 |
| 2015-06-30 | $300.00K 10-Q · filed 2015-08-13 |
| 2015-03-31 | $400.00K 10-Q · filed 2015-05-15 |
| 2014-12-31 | $2.22M 10-K · filed 2015-04-15 |
| 2014-09-30 | $559.36K 10-Q/A · filed 2015-04-15 |
| 2014-03-31 | $2.07M 10-Q/A · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |